Skip to main content
Premium Trial:

Request an Annual Quote

Thomson Reuters Buys GeneGo

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Business information firm Thomson Reuters has bought GeneGo for an undisclosed sum in order to expand its healthcare and life sciences portfolio.

GeneGo, which provides bioinformatics tools for use in drug target selection and validation, biomarker identification, and patient profiling, has become part of Thomson Reuters' Healthcare & Science business segment.

"There is an increasing need for biology content, detailed disease insights, and analytics to support R&D productivity and to enable a more personalized approach to medicine," Jon Brett-Harris, executive vice president at Thomson Reuters, said in a statement Monday.

GeneGo is headquartered in San Diego and has offices in Moscow and in St. Joseph, Mich.

The firm's flagship system is the MetaCore, which provides analysis for microarray gene expression studies, SNPs, metabolic profiles or high-content screening assays. The firm's offerings also include the MetaBase mammalian biology and medicinal chemistry database, and the MetaDrug systems pharmacology platform that can be used to predict human metabolites, toxicity, and mode of action of novel small molecule compounds.

Financial terms of the agreement were not released.

GeneGo said recently that it has integrated its MetaCore solution with Agilent's GeneSpring offering for use in analyzing and handling microarray data, and last month said that it has integrated the MetaCore and MetaDrug products with GenomeQuest's Sequence Data Management platform.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.